United States · Series B startup

Who invested in Second Genome

3 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$19Mraised across 3 rounds since 2011, from 3 sources

$5.0MGrowth$2.5MSeries A$12MSeries B
Latest round
Series B, $12MJun 2013
Step-upi
4.6×
Investors
2
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20122013
$5.0MGrowth$2.5MSeries A$12MSeries B
First round
Growth, $5.0M
Aug 2011
Biggest round
$12M
Series B · Jun 2013
Usual gap between rounds
14 months
the median of 2

The rounds

  1. Jun 2013
  2. Apr 2012
    Series A$2.5M2 new

    From a historical funding record

  3. Aug 2011
    Growth$5.0M

    No investor was named in the report.

    Reported by sec.govSEC filing: $5.0M sold, first sale Jul 2011

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Growth2011Series A2012Series B2013Morgenthaler VenturesAdvanced Technology Ventures

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Second Genome

Who invested in Second Genome?

Second Genome's investors include Morgenthaler Ventures and Advanced Technology Ventures.

How much has Second Genome raised?

Second Genome has raised $19M across 3 rounds since 2011.

When did Second Genome last raise?

Second Genome's most recent round was a Series B of $12M in Jun 2013.

What was Second Genome's biggest round?

Its most recent round, $12M in Jun 2013, is also its largest on record.

Who backed Second Genome first?

Second Genome's first round on record, in Apr 2012, was backed by Morgenthaler Ventures and Advanced Technology Ventures.

What stage is Second Genome at?

Second Genome's latest named round is a Series B, in Jun 2013.

Where is Second Genome based?

Second Genome is based in the United States.

Companies like Second Genome

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.